Heightened Regulatory Scrutiny in China: What Investors Need to Know (Franklin Templeton)

China has announced recent regulatory changes targeting specific industries, which has led to some heighted market volatility. Franklin Templeton’s Emerging Markets Equity team examines what the changes are, why they were implemented, and the potential implications for investors. READ MORE

Similar Posts:

• China’s Regulatory Tightening: Our View on Goals and Scope (Franklin Templeton)
• Evergrande and China: A Lehman Moment—or Less “Grande” Than That? (Franklin Templeton)
• Evergrande Crisis and Contagion Risks (Franklin Templeton)
• Health Care: The Next Wave of Innovation in China (Franklin Templeton)
• The Race to Harness AI Technology in Asia (Franklin Templeton)
• The New Emerging Markets Landscape: Policy Improvements Should Contribute to Increased Resilience (Franklin Templeton)
• Emerging Markets Experience a Volatile First Quarter (Franklin Templeton Investments)
• Changes to the Emerging Markets Club: China (A Shares), Argentina and Saudi Arabia (Franklin Templeton)
• Templeton’s Chow: “No Reason the Goat and the Bull Cannot be Friends” (Mobius Blog)
• October EM Market Recap and Outlook: A Sea of Opportunities (Franklin Templeton)